Overview

Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia

Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Efficacy and safety of Tandospirone combined with Atypical Antipsychotic drugs to Improve Cognitive function in Schizophrenia
Phase:
Phase 4
Details
Lead Sponsor:
Qingyun Yin
Treatments:
Antipsychotic Agents
Aripiprazole
Olanzapine
Quetiapine Fumarate
Risperidone
Tandospirone
Ziprasidone